A Novel Mechanism of Salvianolic Acid B in Postmyocardial Infarction Cardiac Protection: PHB1-Driven Raf-ERK Pathway Activation Promotes Cardiomyocyte Mitosis.
Ce Cao, Bo Ma, Jian Zhang, Lili Yang, Zixin Liu, Haoran Li, Jianshu Song, Keer Zhang, Lei Li, Jianhua Fu and 1 more
Article in MedComm, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
11 authors.
Ce CaoNational Clinical Research Center for Chinese Medicine Cardiology Beijing Key Laboratory of Chinese Materia Pharmacology Xiyuan Hospital of China Academy of Chinese Medical Sciences Beijing China.ORCID https://orcid.org/0000-0002-9901-663X
Bo MaState Key Laboratory of Bioactive Substance and Function of Natural Medicines Institute of Materia Medica Chinese Academy of Medical Sciences and Peking Union Medical College Beijing China.
Jian ZhangDepartment of Critical Care Medicine Meizhou Hospital of Guangzhou University of Chinese Medicine Meizhou China.
Lili YangNational Clinical Research Center for Chinese Medicine Cardiology Beijing Key Laboratory of Chinese Materia Pharmacology Xiyuan Hospital of China Academy of Chinese Medical Sciences Beijing China.
Zixin LiuNational Clinical Research Center for Chinese Medicine Cardiology Beijing Key Laboratory of Chinese Materia Pharmacology Xiyuan Hospital of China Academy of Chinese Medical Sciences Beijing China.
Haoran LiNational Clinical Research Center for Chinese Medicine Cardiology Beijing Key Laboratory of Chinese Materia Pharmacology Xiyuan Hospital of China Academy of Chinese Medical Sciences Beijing China.
Jianshu SongNational Clinical Research Center for Chinese Medicine Cardiology Beijing Key Laboratory of Chinese Materia Pharmacology Xiyuan Hospital of China Academy of Chinese Medical Sciences Beijing China.
Keer ZhangSecond Clinical College Guangzhou University of Chinese Medicine Guangzhou China.
Lei LiNational Clinical Research Center for Chinese Medicine Cardiology Beijing Key Laboratory of Chinese Materia Pharmacology Xiyuan Hospital of China Academy of Chinese Medical Sciences Beijing China.
Jianhua FuNational Clinical Research Center for Chinese Medicine Cardiology Beijing Key Laboratory of Chinese Materia Pharmacology Xiyuan Hospital of China Academy of Chinese Medical Sciences Beijing China.
Jianxun LiuNational Clinical Research Center for Chinese Medicine Cardiology Beijing Key Laboratory of Chinese Materia Pharmacology Xiyuan Hospital of China Academy of Chinese Medical Sciences Beijing China.
Funding
No grant is acknowledged in the PubMed record.
6 · The paper itself
Abstract
Heart failure (HF) following myocardial infarction remains a leading cause of global morbidity and mortality, necessitating novel therapeutic strategies. Salvianolic acid B (SalB), one of the major active components of
Indexed as
cardiomyocyte proliferationcell cycleProhibitin 1Raf‐ERK pathwaysalvianolic acid B
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
A Novel Mechanism of Salvianolic Acid B in Postmyocardial Infarction Cardiac Protection: PHB1-Driven Raf-ERK Pathway Activation Promotes Cardiomyocyte Mitosis. · full record | OpenQuestion